Bayer CropScience Limited disclosed its unaudited financial results for the quarter ended June 30, 2026 (Q1 FY2027) through a regulatory filing to BSE Limited. The Board of Directors approved these results at their meeting held on August 5, 2026, which commenced at 4:30 PM IST and concluded at 5:00 PM IST.

Financial Performance Highlights (₹ in millions)

Income Statement:

  • Revenue from operations: ₹18,350 (compared to ₹11,008 in Q1 FY2026 and ₹19,146 in Q4 FY2026)
  • Other income: ₹889 (includes gain on divestment of marketing rights)
  • Total income: ₹19,239
  • Total expenses: ₹15,218
  • Profit before tax: ₹4,021
  • Total tax expense: ₹805 (Current tax: ₹814, Deferred tax: ₹-9)
  • Profit for the period: ₹3,216
  • Other comprehensive income: ₹-5 (primarily remeasurement loss of defined benefit plan)
  • Total comprehensive income: ₹3,211

Comparative Performance:

  • Q1 FY2027 profit of ₹3,216 million represents a 99% increase from Q1 FY2026 profit of ₹1,621 million
  • Revenue growth of 67% year-over-year from ₹11,008 million to ₹18,350 million

Key Financial Metrics:

  • Paid-up equity share capital: ₹449 million (face value ₹10 per share)
  • Cost of materials consumed: ₹10,427 million
  • Employee benefits expense: ₹1,128 million
  • Depreciation and amortization expense: ₹501 million
  • Finance costs: ₹43 million

Other Income Breakdown

Other income of ₹889 million includes a significant gain of ₹639 million from the divestment of marketing rights for formulated products. This compares to ₹223 million gain from the same source in the year ended March 31, 2026.

Business Segment Information

The company has only one reportable business segment: "Agri Care." The business is seasonal in nature, and quarterly figures are not necessarily representative of full-year performance.

Corporate Structure

The company does not have any subsidiaries, joint ventures, or associate companies and is not required to prepare consolidated financial results.

Audit and Review

The financial results were subjected to limited review by the statutory auditors, Deloitte Haskins & Sells LLP (ICAI Firm Registration No. 117366W/W-100018), who issued an independent auditor's review report. The audit committee reviewed and recommended the results before board approval.

Signatories and Certifications

The disclosure was signed by Bharati Ratan Shetty, Company Secretary and Compliance Officer (Membership No.: ACS 24199). The financial results were approved by Vinit Rajesh Jindal, Executive Director and Chief Financial Officer (DIN: 10849465).